Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Newly Diagnosed Primary Acquired PRCA
NCT04470804Phase 4Completed
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sirolimus in acquired pure red cell aplasia (PRCA). Started Jul 2020; status: completed.
02
Drugs
sirolimus
03
Conditions
acquired pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT04470804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470804.